118 related articles for article (PubMed ID: 38902550)
21. Accuracy of controlled attenuation parameter for assessing liver steatosis in individuals with morbid obesity before bariatric surgery.
Tavaglione F; De Vincentis A; Bruni V; Gallo IF; Carotti S; Tuccinardi D; Spagnolo G; Ciociola E; Mancina RM; Jamialahmadi O; D'Alessio R; Bottazzi B; Manfrini S; Picardi A; Perrone G; Pozzilli P; Caricato M; Vespasiani-Gentilucci U; Romeo S
Liver Int; 2022 Feb; 42(2):374-383. PubMed ID: 34890093
[TBL] [Abstract][Full Text] [Related]
22. Ultrasound hepatic/renal ratio and hepatic attenuation rate for quantifying liver fat content.
Zhang B; Ding F; Chen T; Xia LH; Qian J; Lv GY
World J Gastroenterol; 2014 Dec; 20(47):17985-92. PubMed ID: 25548498
[TBL] [Abstract][Full Text] [Related]
23. Reliability of ultrasound hepatorenal index and magnetic resonance imaging proton density fat fraction techniques in the diagnosis of hepatic steatosis, with magnetic resonance spectroscopy as the reference standard.
Tran BV; Ujita K; Taketomi-Takahashi A; Hirasawa H; Suto T; Tsushima Y
PLoS One; 2021; 16(8):e0255768. PubMed ID: 34383812
[TBL] [Abstract][Full Text] [Related]
24. Controlled attenuation parameter and alcoholic hepatic steatosis: Diagnostic accuracy and role of alcohol detoxification.
Thiele M; Rausch V; Fluhr G; Kjærgaard M; Piecha F; Mueller J; Straub BK; Lupșor-Platon M; De-Ledinghen V; Seitz HK; Detlefsen S; Madsen B; Krag A; Mueller S
J Hepatol; 2018 May; 68(5):1025-1032. PubMed ID: 29343427
[TBL] [Abstract][Full Text] [Related]
25. Susceptibility based multiparametric quantification of liver disease: Non-invasive evaluation of steatosis and iron overload.
Uhrig M; Mueller J; Longerich T; Straub BK; Buschle LR; Schlemmer HP; Mueller S; Ziener CH
Magn Reson Imaging; 2019 Nov; 63():114-122. PubMed ID: 31425813
[TBL] [Abstract][Full Text] [Related]
26. [Value of hydrogen proton magnetic resonance spectroscopy in the determination of liver triglyceride in patients with fatty liver disease and its influencing factors].
Qu HJ; Wang L; Jin PH; Gao Q; Zhou JX; Song Y; Wang J; Jiang YM; Gong L; Chen GY; Ding JP; Shi JP
Zhonghua Gan Zang Bing Za Zhi; 2017 Nov; 25(11):858-863. PubMed ID: 29325281
[No Abstract] [Full Text] [Related]
27. The diagnostic value of novel ultrasound attenuation analysis in detecting liver steatosis identified by the controlled attenuation parameter: a diagnostic accuracy study.
Jiang M; Zhang X; Wu X; Xu Z; Pan J; He H; Luo Y; Chen J
Ann Transl Med; 2023 Jan; 11(2):38. PubMed ID: 36819532
[TBL] [Abstract][Full Text] [Related]
28. Assessment of Imaging Modalities Against Liver Biopsy in Nonalcoholic Fatty Liver Disease: The Amsterdam NAFLD-NASH Cohort.
Troelstra MA; Witjes JJ; van Dijk AM; Mak AL; Gurney-Champion O; Runge JH; Zwirs D; Stols-Gonçalves D; Zwinderman AH; Ten Wolde M; Monajemi H; Ramsoekh S; Sinkus R; van Delden OM; Beuers UH; Verheij J; Nieuwdorp M; Nederveen AJ; Holleboom AG
J Magn Reson Imaging; 2021 Dec; 54(6):1937-1949. PubMed ID: 33991378
[TBL] [Abstract][Full Text] [Related]
29. Quantitative Ultrasound Radiofrequency Data Analysis for the Assessment of Hepatic Steatosis in Nonalcoholic Fatty Liver Disease Using Magnetic Resonance Imaging Proton Density Fat Fraction as the Reference Standard.
Jeon SK; Lee JM; Joo I; Park SJ
Korean J Radiol; 2021 Jul; 22(7):1077-1086. PubMed ID: 33739636
[TBL] [Abstract][Full Text] [Related]
30. Controlled attenuation parameter (CAP): the clinical value based on MRI-PDFF in children with obesity.
Peng T; Yi X; Lin Y; Dong X; Zhang P; Qiao Z; Li L
J Pediatr Endocrinol Metab; 2024 May; ():. PubMed ID: 38723170
[TBL] [Abstract][Full Text] [Related]
31. Controlled attenuation parameter accurately detects liver steatosis in people with HIV.
Duarte M; Tien P; Ma Y; Noworolski SM; Korn N; Price JC
AIDS; 2022 Dec; 36(15):2147-2152. PubMed ID: 35950941
[TBL] [Abstract][Full Text] [Related]
32. Clinical usefulness of controlled attenuation parameter to screen hepatic steatosis for potential donor of living donor liver transplant.
Hong YM; Yoon KT; Cho M; Chu CW; Rhu JH; Yang KH; Lee JW
Eur J Gastroenterol Hepatol; 2017 Jul; 29(7):805-810. PubMed ID: 28379854
[TBL] [Abstract][Full Text] [Related]
33. [Applied research of ultrasound attenuation parameter in the diagnosis of metabolic dysfunction-associated fatty liver disease].
Hou MM; Yuan XW; Wang YQ; Zhang Y; Zhang SY; Yu SH; Nan YM
Zhonghua Gan Zang Bing Za Zhi; 2022 Mar; 30(3):290-296. PubMed ID: 35462485
[No Abstract] [Full Text] [Related]
34. Controlled attenuation parameter (CAP) for detection of hepatic steatosis in patients with chronic liver diseases: a prospective study of a native Korean population.
Chon YE; Jung KS; Kim SU; Park JY; Park YN; Kim DY; Ahn SH; Chon CY; Lee HW; Park Y; Han KH
Liver Int; 2014 Jan; 34(1):102-9. PubMed ID: 24028214
[TBL] [Abstract][Full Text] [Related]
35. Diagnostic performance of ultrasound attenuation imaging for assessing low-grade hepatic steatosis.
Jang JK; Kim SY; Yoo IW; Cho YB; Kang HJ; Lee DH
Eur Radiol; 2022 Mar; 32(3):2070-2077. PubMed ID: 34549325
[TBL] [Abstract][Full Text] [Related]
36. Controlled Attenuation Parameter for Assessment of Hepatic Steatosis in Indian Patients.
Rout G; Kedia S; Nayak B; Yadav R; Das P; Acharya SK; Gunjan D; Singh V; Mahanta M; Gupta S; Aggarwal S; Shalimar
J Clin Exp Hepatol; 2019; 9(1):13-21. PubMed ID: 30765934
[TBL] [Abstract][Full Text] [Related]
37. Sonographic hepatic-renal ratio as indicator of hepatic steatosis: comparison with (1)H magnetic resonance spectroscopy.
Mancini M; Prinster A; Annuzzi G; Liuzzi R; Giacco R; Medagli C; Cremone M; Clemente G; Maurea S; Riccardi G; Rivellese AA; Salvatore M
Metabolism; 2009 Dec; 58(12):1724-30. PubMed ID: 19716568
[TBL] [Abstract][Full Text] [Related]
38. Diagnostic accuracy of ultrasound-guided attenuation parameter as a noninvasive test for steatosis in non-alcoholic fatty liver disease.
Kuroda H; Abe T; Fujiwara Y; Nagasawa T; Takikawa Y
J Med Ultrason (2001); 2021 Oct; 48(4):471-480. PubMed ID: 34415481
[TBL] [Abstract][Full Text] [Related]
39. Quick assessment with controlled attenuation parameter for hepatic steatosis in children based on MRI-PDFF as the gold standard.
Shin J; Kim MJ; Shin HJ; Yoon H; Kim S; Koh H; Lee MJ
BMC Pediatr; 2019 Apr; 19(1):112. PubMed ID: 30987634
[TBL] [Abstract][Full Text] [Related]
40. A meta-analysis on the diagnostic performance of magnetic resonance imaging and transient elastography in nonalcoholic fatty liver disease.
Gu Q; Cen L; Lai J; Zhang Z; Pan J; Zhao F; Yu C; Li Y; Chen C; Chen W; Shen Z
Eur J Clin Invest; 2021 Feb; 51(2):e13446. PubMed ID: 33128454
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
